Skip to main content
OpenTrials

Clinical trial condition

Endometrial Adenocarcinoma

Explore clinical trials studying Endometrial Adenocarcinoma. Study availability and eligibility vary by location and protocol.

47 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Adenocarcinoma trial results

Completed

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

NCT00478426

Conditions
Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma, +5 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 29 locations
View Trial Details
Completed

Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT01132820

Conditions
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +2 more
Locations
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Palo Alto Medical Foundation-Gynecologic Oncology Mountain View, California, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
View all 87 locations
View Trial Details
Completed

Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT01011933

Conditions
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +1 more
Locations
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Hartford Hospital Hartford, Connecticut, United States
View all 72 locations
View Trial Details
Completed

Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer

NCT01005329

Conditions
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +9 more
Locations
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • John Muir Medical Center-Walnut Creek Walnut Creek, California, United States
  • Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 41 locations
View Trial Details
Completed

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

NCT01642082

Conditions
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, +6 more
Locations
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
  • Florida Hospital Orlando Orlando, Florida, United States
View all 30 locations
View Trial Details

Related conditions